Shareholders of Achillion Pharmaceuticals have overwhelmingly approved the company’s takeover by fellow New Haven-born drug maker Alexion Pharmaceuticals for $930 million.
Achillion said approximately 99 percent of shareholders voted in favor of the deal during a special meeting Thursday morning.